Trial · NCT00021229
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Stratum I: Radiation + Imatinib Mesylate | 36 | |
| Overall Study | STARTED | Stratum IIA: Imatinib Mesylate | 33 | |
| Overall Study | STARTED | Stratum IIB: Imatinib Mesylate | 16 | |
| Overall Study | Enrolled in Phase I | Stratum I: Radiation + Imatinib Mesylate | 35 | |
| Overall Study | Enrolled in Phase I | Stratum IIA: Imatinib Mesylate | 33 | |
| Overall Study | Enrolled in Phase I | Stratum IIB: Imatinib Mesylate | 16 | |
| Overall Study | Maximum Tolerated Dose (MTD) Estimation | Stratum I: Radiation + Imatinib Mesylate | 23 | |
| Overall Study | Maximum Tolerated Dose (MTD) Estimation | Stratum IIA: Imatinib Mesylate | 20 | |
| Overall Study | Maximum Tolerated Dose (MTD) Estimation | Stratum IIB: Imatinib Mesylate | 12 | |
| Overall Study | Enrolled in Phase II | Stratum I: Radiation + Imatinib Mesylate | 14 | |
| Overall Study | Enrolled in Phase II | Stratum IIA: Imatinib Mesylate | 0 | |
| Overall Study | Enrolled in Phase II | Stratum IIB: Imatinib Mesylate | 0 | |
| Overall Study | COMPLETED | Stratum I: Radiation + Imatinib Mesylate | 1 | |
| Overall Study | COMPLETED | Stratum IIA: Imatinib Mesylate | 0 | |
| Overall Study | COMPLETED | Stratum IIB: Imatinib Mesylate | 0 | |
| Overall Study | NOT COMPLETED | Stratum I: Radiation + Imatinib Mesylate | 35 | |
| Overall Study | NOT COMPLETED | Stratum IIA: Imatinib Mesylate | 33 | |
| Overall Study | NOT COMPLETED | Stratum IIB: Imatinib Mesylate | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00021229/flow